• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call

    5/27/25 4:05:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $PETS alert in real time by email

    DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call.

    PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time.

    Date: Tuesday, June 10, 2025

    Time: 4:30pm Eastern Time (1:30pm Pacific Time)

    U.S. dial-in number: 877-407-0789

    International number: 201-689-8562

    Webcast: 4Q Earnings Webcast

    A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through June 24, 2025.

    Toll-free replay number: 844-512-2921

    International replay number: 412-317-6671

    Replay passcode: 13753433

    About PetMed Express, Inc.

    Founded in 1996, PetMeds is a pioneer in the direct-to- consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness and the veterinarians who serve them. Through its PETS family of brands, the company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.

    Investor Contact:

    ICR, LLC

    John Mills

    (646) 277-1254

    Reed Anderson

    (646) 277-1260

    [email protected]



    Primary Logo

    Get the next $PETS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETS

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    More analyst ratings

    $PETS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Nina Capital Holdings Inc. bought $98,375 worth of shares (25,000 units at $3.94), increasing direct ownership by 0.99% to 2,550,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      6/4/25 4:15:58 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $96,500 worth of shares (25,000 units at $3.86), increasing direct ownership by 1% to 2,525,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/23/25 4:15:13 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Silvercape Investments Ltd bought $29,234 worth of shares (7,401 units at $3.95), increasing direct ownership by 0.32% to 2,307,719 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/22/25 10:55:21 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on PetMed Express with a new price target

      Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00

      5/25/23 9:17:49 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Morgan Stanley reiterated coverage on PetMed Express with a new price target

      Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously

      1/25/22 10:17:17 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express upgraded by Sidoti with a new price target

      Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00

      1/20/22 9:13:56 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples